Compounds > bufalin

bufalin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

bufalin has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, H; Kuroiwa, Y; Numazawa, S; Shinoki, MA; Yoshida, T1
Kuroiwa, Y; Nakaya, K; Yoshida, T; Zhang, LS1

Other Studies

2 other study(ies) available for bufalin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Involvement of Na+,K(+)-ATPase inhibition in K562 cell differentiation induced by bufalin.
    Journal of cellular physiology, 1994, Volume: 160, Issue:1

    Topics: Animals; Bufanolides; Cell Differentiation; Cell Transformation, Neoplastic; Drug Resistance; Humans; Leukemia, Experimental; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Ouabain; Sodium-Potassium-Exchanging ATPase; Tritium; Tumor Cells, Cultured

1994
Bufalin as a potent inducer of differentiation of human myeloid leukemia cells.
    Biochemical and biophysical research communications, 1991, Jul-31, Volume: 178, Issue:2

    Topics: Bufanolides; Cell Differentiation; Cell Line; Digitoxigenin; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Materia Medica; Molecular Structure; Ouabain

1991